Rancinamycins I, II, III and IV structural studies
Related Experiment Videos
The Journal of Antibiotics
|August 1, 1976
Abstract:
Rancinamycins are secondary metabolites produced by Streptomyces lincolnensis in a sulfur-depleted culture medium. The structures (except stereochemistry) of the main components of the rancinamycin-complex were determined by the use of IR, UV, PMR, and CMR spectra.
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Syntheses of 1,2-diamino and 1,2-aminoalcohol derivatives in the piperidine and pyrrolidine series as anti-amnesic agents.
Bioorganic & medicinal chemistry·1999
Syntheses of benzoquinolizidine and benzoindolizidine derivatives as anti-amnesic agents.
Bioorganic & medicinal chemistry·1999
Isolation and identification of a major metabolite of PNU-107859, an MMP inhibitor from the biliary fluid of rats.
Journal of pharmaceutical sciences·1999
Solution structures of stromelysin complexed to thiadiazole inhibitors.
Protein science : a publication of the Protein Society·1998
In vitro metabolic transformations of 2,4-dipyrrolidinylpyrimidine: a chemical probe for P450-mediated oxidation of tirilazad mesylate.
Xenobiotica; the fate of foreign compounds in biological systems·1997
Enzymatic installation of post-translational modifications into artificial peptides using RiPP biosynthetic machinery.
The Journal of antibiotics·2026
Isolation and characterization of 5-O-desmethyl kinanthraquinone B generated through O-methyltransferase gene disruption.
The Journal of antibiotics·2026
An unusual follower peptide is required for biosynthesis of the antibiotic lasso peptide triculamin.
The Journal of antibiotics·2026
Endophytic extract from Zanthoxylum piperitum as a promising source of anti-SARS-CoV-2 agents.
The Journal of antibiotics·2026
Pobacilamides A and B, two linear depsipeptides from a marine-derived Bacillus sp. ROA-056.
The Journal of antibiotics·2026
Inflammatory biomarkers of obstructive sleep apnea: a comprehensive review from known to novel.
Molecular biology reports·2026